Stephen Globus

From Wikipedia, the free encyclopedia

Stephen Globus is a New York City Venture Capitalist who is third generation from a prominent banking family. He is currently a founder and director of China Biopharmaceuticals Holdings which is a major Medical Company in China. He was a founding shareholder of Genitope Corporation which is a San Francisco area biotechnology company that designs custom treatments for cancer including a vaccine to treat Lymphoma.

Mr. Globus also was founder and Chairman of PlasmaCo^[1] which developed color plasma television and sold to Osaka based Matsushita (Panasonic) in 1996. Globus was on the Japanese Board of Directors for the proceeding 7 years after the sale. His other ventures activities include key investment or managerial roles in Proscure (sold to Repligen), ExSar, Kimeragen which sold to a Paris based Company which Board Mr. Globus served on, Energy Research (Fuel Cell Energy), Nematron, and Tinsley Laboratories which developed the optic correction for Hubble Space Telescope now a division of the Dutch company ASML .

Stephen E. Globus holds patents on panoramic cameras called the Globuscope and optics. Mr. Globus is a founder of Globus Studios in Central Manhattan. He is patron of the arts with associations such as Japan Society of New York and China Institute in America.

References

↑ Tiwari, Ashutosh (2012-02-21). Intelligent Nanomaterials. John Wiley & Sons. pp. 92–. ISBN 9781118311967. Retrieved 5 July 2012.

Persondata
Name	Globus, Stephen
Alternative names
Short description	Businessperson
Date of birth
Place of birth
Date of death
Place of death

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.